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AbstrACt
Introduction The singing for people with aphasia (SPA) 
intervention aims to improve quality of life and well-being 
for people with poststroke aphasia. A definitive randomised 
controlled trial (RCT) is required to assess the clinical and 
cost effectiveness of SPA. The purpose of this pilot study is 
to assess the feasibility of such a definitive trial and inform 
its design.
Methods and analysis A two-group, assessor-blinded, 
randomised controlled external pilot trial with parallel 
mixed methods process evaluation and economic 
evaluation. Forty-eight participants discharged from 
clinical speech and language therapy will be individually 
randomised 1:1 to SPA (10 group sessions plus a 
resource booklet) or control (resource booklet only). 
Outcome assessment at baseline, 3 and 6 months 
postrandomisation include: ICEpop CAPability measure 
for adults, Stroke and Aphasia Quality of Life, EQ-5D-
5L, modified Reintegration into Normal Living Index, 
Communication Outcome After Stroke, Very Short Version 
of the Minnesota Aphasia Test, Service Receipt Inventory 
and Care Related Quality of Life. Feasibility, acceptability 
and process outcomes include recruitment and retention 
rates, with measurement burden and trial experiences 
being explored in qualitative interviews (15 participants, 
2 music facilitators and 2 music champions). Analyses 
include: descriptive statistics, with 95% CIs where 
appropriate; qualitative themes; intervention fidelity 
from videos and session checklists; rehearsal of health 
economic analysis.
Ethics and dissemination NHS National Research Ethics 
Service and the Health Research Authority confirmed 
approval in April 2017; recruitment commenced in June 
2017. Outputs will include: pilot data to inform whether 
to proceed to a definitive RCT and support a funding 
application; finalised intervention manual for multicentre 
replication of SPA; presentations at conferences, public 
involvement events; internationally recognised peer 
reviewed journal publications, open access sources and 
media releases.
trial registration number NCT03076736.
IntroduCtIon 
Mortality rates following stroke are falling, 
but stroke remains a major cause of disability. 
About 33% of the 152 000 people affected by 
a stroke each year in the UK have aphasia.1 
Aphasia is a language disorder impacting 
on gesture, reading/writing, expression and 
comprehension of speech. In Devon, where 
we will conduct the proposed research, there 
are approximately 6000 people living with 
this condition.2 
As well as impaired language functioning, 
people with aphasia often report poor 
psychosocial health, including reduced social 
participation, social isolation and lower levels 
of overall well-being—outcomes exacerbated 
by low levels of confidence and self-efficacy in 
social situations3 4—and also depression and 
distress.5 Stroke survivors without aphasia also 
experience ill-health psychosocial outcomes 
but they are substantially worse in people 
with aphasia.3 While speech and language 
therapy can improve functional communica-
tion of people with aphasia,6 there is a paucity 
of evidence for its impact on psychosocial 
strengths and limitations of this study
 ► Built on a strong theoretical framework, this inter-
vention takes an important step towards the explo-
ration of improving psychosocial health for people 
living with poststroke aphasia.
 ► This study focuses on people with poststroke apha-
sia: an often neglected and under-represented pa-
tient population in research.
 ► This pilot randomised controlled trial study meets 
the MRC guidance on the development and evalua-
tion of complex interventions and includes compre-
hensive patient and public involvement.
 ► This small scale study will be used to estimate be-
tween-group differences in outcomes, but does not 
have sufficient statistical power to make inferential 
between-group comparisons.
 ► The follow-up periods are relatively short compared 
with what would be necessary in a fully funded de-
finitive trial.
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outcomes: improvements in language do not appear to 
translate to significant improvements in well-being.7
Accordingly, guidelines recommend that rehabilita-
tion should integrate people with aphasia back into the 
community and into social roles in order to improve 
psychosocial health.8 However, there is a notable lack 
of opportunities for people with aphasia in this regard; 
those available (eg, local support groups) often are aimed 
at all stroke survivors, which may not meet the specific 
psychosocial needs of people with aphasia.9 People with 
aphasia can lack the confidence to take up opportunities 
within the community which for others may seem more 
accessible.10
Our project will pilot a new group singing interven-
tion for improving psychosocial health in people with 
aphasia. The intervention is complex and integrates the 
established Information-Motivation-Behavioural (IMB) 
skills model of health behaviour change11 to support 
individuals in developing the social skills and confi-
dence needed to improve psychosocial outcomes. There 
is a growing interest in the potential benefits of group 
interventions, including those focused on music making 
and singing, for those with long-term conditions.12–15 
Social groups represent a valuable basis for self-defini-
tion, self-esteem and belonging and provide a ‘lens’ or 
social identity through which people make sense of their 
health.16–20 Groups provide support to members, known 
to be important to psychosocial functioning and adjust-
ment, and they motivate behaviour and achievement of 
behavioural goals.16 21 When people lose their connec-
tion to others (such as with aphasia), their capacity to 
interact successfully with the social world (and ultimately 
their health and well-being) is significantly compro-
mised.22 Providing opportunities for such people to join 
social groups offers a means of developing meaningful 
relationships with other people and reconnecting with 
society.23–26 Our project draws on and expands this litera-
ture following principles of intervention design outlined 
in the MRC framework.27
The core research question was put forward by a local 
stroke survivor who asked ‘What are the benefits of 
singing for people with aphasia following stroke?’ An 
initial scoping review revealed several case studies whose 
focus tended to be on impairment-based outcomes (with 
a debate as to whether singing in particular can impact 
on speech production).28–31 Notably, there were no 
randomised controlled trials (RCTs), either of group-
based or individual-based interventions, that targeted 
psychosocial outcomes of people with aphasia (or 
stroke more broadly) which would make the current 
project redundant. Some uncontrolled studies and 
studies employing qualitative methods suggested poten-
tial benefits of group singing on well-being for people 
with aphasia.12 These observations resonate with our 
own recent development study, in which 10 people with 
aphasia participated in the first session of the new inter-
vention,32 and also discussions with people with aphasia 
who have offered enthusiastic support for a new group 
intervention that focuses on singing and targets more 
directly the psychosocial problems that they experience.
Many people with aphasia retain the ability to sing33 and 
are able to participate in music-making activities. Most 
people enjoy music and singing, and group singing is by 
definition social, demanding cooperation and coordina-
tion between participants.12 34 People with aphasia in our 
development study told us that being in a singing group, 
more so than other activities like arts and crafts, would 
help them to interact with other people.32 In short, by 
bringing people with aphasia together in a singing group, 
it may be possible to improve aspects of their life that are 
currently experienced as significant barriers to psychoso-
cial functioning and which are not currently addressed 
through existing healthcare service provision.
Aims
Singing for people with aphasia (SPA) aims to improve 
psychosocial health in people with aphasia by providing 
interactive opportunities which promote confidence (eg, 
in forming new relationships), reduce social isolation and 
increase well-being. A definitive RCT is required to assess 
the effectiveness and cost-effectiveness of the SPA inter-
vention. The purpose of this pilot study is to help us plan 
such a trial. The study will assess whether the interven-
tion is feasible and acceptable to participants, focusing on 
(1) how well we can recruit and retain participants, (2) 
whether we can successfully collect outcome measures at 
different assessment points and (3) how well the interven-
tion can be delivered in different locations with different 
groups. Finally, the study will allow us to document the 
intervention complexity and likely mechanisms of action.
MEthods And AnAlysIs
design
A two-group, assessor-blinded, randomised controlled 
external pilot trial with parallel mixed methods process 
evaluation and economic evaluation. Eligible participants 
will be individually randomised 1:1 to SPA (10 week singing 
programme plus a resource booklet) or control (resource 
booklet only). The design is depicted in figure 1, which 
shows the flow of participants throughout the trial.
Population
People with aphasia are often excluded from research 
on the presumption that they are unable to provide 
consent.35 36 Our intervention is an inclusive interven-
tion which does not discriminate on the basis of aphasia 
severity, time since stroke or singing ability. Additional 
support to engage with the research process may be 
required for people with communication disability and 
cognitive impairment. The Mental Capacity Act37 will 
be used as a framework for assessing participants’ ability 
to make an informed decision about engaging in the 
research. For those with cognitive impairment, we will 
follow NRES guidance on involving personal or nominee 
consultees to facilitate their involvement in research. 
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We will also use Accessible Information Guidance of the 
Stroke Association, and the National Institute of Health 
Research, and work with Speakability, our Service User 
Group (SUG) and a speech and language therapist (SLT) 
to ensure information is appropriately presented (eg, 
including use of pictures).
Potential participants will be included if they meet the 
following inclusion and exclusion criteria: they (1) have 
a diagnosis of aphasia after stroke (via referring clinician; 
the trial SLT via the Minnesota Aphasia Test; GP/medical 
records; self-report or carer-report), (2) are willing to 
be randomised to either control or SPA (and able to 
attend the singing venue), (3) had prestroke conversa-
tional English and (4) have capacity to consent. Potential 
participants will be excluded if they are: (1) less than 18 
years old, (2) currently engaged in a SLT programme, (3) 
Figure 1 Study flowchart.
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intending to relocate outside the geographical region, 
(4) participating in another study involving a lifestyle 
intervention or (5) currently attending a singing/music 
group.
Sample size
The target recruitment number is 48 participants (24 per 
arm). This number is based on the recommendation of 
30 participants with complete data sets for pilot studies 
in order to estimate outcome variance38 and running 
the intervention three times to enable investigation of 
variations in context and other process variables. This 
recruited number is based on an estimate of the attrition 
rate across 6 months of 20% and allows estimation of this 
attrition with a precision of ±13% with 95% certainty.
Participant recruitment
Participants will be recruited from Devon and surrounding 
areas, so participants will be local to the three programme 
delivery sites (Plymouth, South Devon and Exeter). These 
areas cover a population of 250 000 with at least 3000 
stroke survivors who require support with daily activities.2 
To maximise potential involvement, several routes for 
recruitment will be used to reach both those who are just 
leaving SLT services and those who have been discharged 
for some time:
1. South West Peninsula Clinical Research Network 
(Stroke) will identify potential participants using:
 – existing research databases,
 – clinic lists,
 – liaison with local clinicians.
2. SLTs will provide study information and patient infor-
mation sheet (PIS) to potential participants:
 – in person, at the end of their SLT programme,
 – via post, following a database search and review of 
clinic list in order to contact previous SLT users.
3. Direct contact. The study will be advertised with:
 – local support groups,
 – on relevant websites (eg, The Stroke Association) 
and community newsletters.
4. Promotion via local stroke support networks identified 
through national organisations such as the Stroke As-
sociation, Different Strokes and via internet searches 
and in local media (radio and television).
5. Word of mouth, study flyers, adverts and information 
sheets.
For (1) and (2), potential participants will be given 
a PIS, including a brief description of the study and, if 
they are interested, permission will be obtained to pass 
their details to the research team. The participant will 
complete, with assistance if required, an expression of 
interest form, recording their contact details and consent 
for these details to be passed to the research team. Those 
contacted by post will be asked to return the expression 
of interest form by post direct to the research team. For 
(3), (4) and (5) above, potential participants will be able 
to self-refer by contacting the research team. Letters, arti-
cles and posters will be used to provide brief details of 
the study and invite expressions of interest to contact the 
research team by telephone call, email or post.
Because of uncertainty in recruitment rates and patterns 
and the need to have at least 12 people ready for randomi-
sation, some participants may have to wait several weeks 
until sufficient group members have been consented. We 
estimate a delay of 4–8 weeks between consent and rando-
misation. Discussions with regional SLT services indicate 
that these predictions are realistic given the size of the 
local population of likely eligible participants. Once 
there are sufficient numbers, the Trial Manager (TM) will 
arrange a time/date to complete the baseline testing at 
each participant’s home prior to randomisation. During 
the baseline assessment, the battery of questionnaires will 
be worked through with the participant.
Individuals will be informed of the potential delay to 
baseline assessment and randomisation during the initial 
screening phase. Those declining to participate at any 
stage of the recruitment process will be invited to share 
their reason(s) for declining, although will be under no 
obligation to give any.
Randomisation and group allocation
To ensure allocation concealment, participants will be 
allocated 1:1 to either intervention or control arms using a 
web-based randomisation service supported by the Exeter 
Clinical Trials Unit (ExeCTU). We will use a minimisation 
algorithm to ensure balance between groups, stratified by 
aphasia type (fluent vs non-fluent) and severity (mild/
moderate vs severe), gender and site (South Devon, Plym-
outh, Exeter). ExeCTU will perform each randomisation 
and inform the TM of group allocations; the TM will then 
relay group allocations to the participants.
Blinding
Participants, singing group facilitators providing the inter-
vention and researchers conducting the process evalua-
tion cannot be blinded to allocation. However, outcomes 
will be assessed by an independent assessor blinded to 
group allocation. Immediately prior to outcome assess-
ments, participants will be reminded not to disclose their 
allocation to the assessor. Any incidents of unblinding will 
be recorded (including the stage at which it occurred—
prior to, during or postassessment), and the assessor will 
be asked to record their estimate of participant allocation 
prior to undertaking the assessments: we did this success-
fully in an earlier study.39 Following recommended strat-
egies to maintain and assess blinding,40 the outcomes 
assessor will not be based at the research centre.
Intervention
SPA is based in a community centre/facility with 10 
weekly singing group sessions. The intervention was 
developed with input from stroke survivors with aphasia, 
music facilitators, SLTs, health researchers and psychol-
ogists, following principles of participatory design.41 42 
Development meetings covered structural (eg, location, 
facilities, seating arrangements, breaks), musical (eg, 
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song book content and number of songs) and non-musical 
(eg, facilitator-led skills development) issues, including a 
consideration of potential barriers to and facilitators of 
participant engagement with the singing sessions.32
Each SPA session will last 90 min, comprising 30 min of 
settling in/wrap-up and departure and 60 min of group 
singing. Sessions will be led by a community music 
leader, cofacilitated by a person with aphasia (‘music 
champion’), and involve the group singing songs from a 
songbook. Song flow is aided by musical accompaniment 
(keyboard/guitar) provided by the facilitator(s). Small 
auxiliary percussion instruments (eg, shakers, tambou-
rines) will be available for participants to play, enabling 
involvement of those with limited singing ability. Inter-
vention content integrates the IMB skills model of 
health behaviour change11 to support individuals in 
developing the social skills and confidence needed to 
improve psychosocial outcomes. Providing people with 
information which they may lack (eg, about potential 
well-being benefits of participating in a singing group), 
bolstering change motivation (eg, providing positive 
feedback on participation) and teaching behavioural 
skills (eg, self-monitoring of behaviour and outcomes) 
are central to the IMB model and are also integral to our 
intervention. We draw on this framework to encourage 
formation of shared social identity among group partic-
ipants from the outset of the singing programme and 
employ specific techniques from it to ensure its mainte-
nance across the programme (eg, through the use of: an 
singing champion, inclusive language, group name and 
goal setting). Figure 2 describes the IMB skills compo-
nents of each session. Sessions 2–9 will be flexible in 
terms of when each IMB skills component will be intro-
duced, so as to accommodate individual progression 
within the group (the importance of which was empha-
sised in our earlier development study32); only a selec-
tion of nominated components will be used in any one 
session.
An Intervention Delivery manual will be developed 
and refined as part of the feasibility work of this study 
and will specify the essential resources, activities and 
behaviours of both facilitators and recipients that must 
be present in sessions and across the programme. 
Session check lists, completed by facilitators, will capture 
whether the main content of the Intervention Manual 
is being delivered, indicate where flexibility of delivery 
is permitted (in session structure/content) and allow 
evaluation of intervention fidelity. The trial SLT will 
contribute to training of music facilitators with a partic-
ular focus on overcoming potential barriers to partici-
pant communication.
Control
All participants (intervention and control) receive treat-
ment as usual (which will be recorded) and a resource 
pack which collates information about living with aphasia 
and local community activities.
Assessment and outcomes
Initial screening assessment
Once a potential participant has been identified and has 
agreed to be contacted, the TM or Associate Research 
Fellow (ARF) will contact them to explain the study in full, 
answer questions and undertake eligibility screening. A 
family member, carer or guardian of the potential partic-
ipant may speak with us on behalf of the participant. If a 
potential participant is unable to communicate over the 
phone and no carer or family member can answer eligi-
bility questions on their behalf, we will visit them at home. 
Basic demographic data (eg, gender, date of birth, time 
since stroke) will also be collected during the exchange. 
For those who choose not to participate (or who are not 
eligible) at this stage, data will still be collected if the 
individual is happy to provide it. These data will allow 
description of the sample approached compared with the 
target population. After talking to a potential participant 
about the trial, eligible participants will be encouraged 
to think about taking part and to discuss the study with 
their family/friends/carers before making a decision. 
Anyone who is not eligible to take part will be thanked 
and informed that they are unable to participate. Poten-
tially eligible participants will be asked to provide verbal 
consent for the study team to contact their GP to confirm 
the diagnosis of stroke and aphasia, if recorded on the 
patient records. This verbal consent will be documented 
by the research staff. One week later the TM or ARF will 
telephone, email or send a letter to the eligible partic-
ipant to ask whether they would like to take part in the 
research study. If the person is agreeable, a home visit 
from the TM or ARF will be arranged and the TM or ARF 
will conduct further screening to confirm eligibility and 
will obtain written consent from eligible participants. 
Following this, full demographic and medical history data 
will be collected. If in the interim the GP report indicates 
an individual is not eligible for the trial, the study team 
will contact the individual and inform them that they are 
unable to participate. Any scheduled home visit will be 
cancelled.
Home-based screening and data collection
Those apparently eligible for inclusion will be visited 
at home by a member of the research team to provide 
further information about the study, confirm eligibility 
and to obtain written consent. Although potential partic-
ipants will be asked at this time to give their consent for 
being video-recorded and photographed during singing 
sessions (should they be allocated to the intervention 
arm), and for taking part in an interview about their 
experiences at the end of the trial, these activities will also 
be specifically consented later in the trial process. Partic-
ipants will be informed that video and photographic 
records are to allow the research team to retain a record 
of their activities and that we may present these images, 
with their permission, for academic or educational 
purposes. During the singing sessions, all participants will 
be asked to provide verbal consent immediately prior to 
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video-recording or having their photograph taken so that 
they can confirm or change their original consent. They 
will also be asked whether they would like their face to be 
blurred out during any editing of the recordings. Carers 
and singing group facilitators attending group singing 
sessions or interviews will be taken through the same 
consenting procedures as the participants.
Demographic and other personal information collected 
at the consent visit comprise:
 ► Date of birth, gender, ethnicity.
 ► Stroke and aphasia history (Very Short Version of the 
Minnesota Aphasia Test,43 summary of speech and 
language therapy including length of programme, 
duration of sessions, confirmation of discharge). 
Participants’ completion of the Very short Minnesota 
Aphasia Test will be audio recorded so that the trial 
SLT can categorise severity of aphasia. Audio record-
ings will be permanently deleted after categorisation.
 ► Modified Rankin Scale Score.44
 ► Medical history (comorbidities, current treatments).
Figure 2 The IMB skills components of the SPA programme. IMB, Information-Motivation-Behavioural skills; SPA, singing for 
people with aphasia 
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 ► Social history (employment status, previous employ-
ment, Index of Multiple Deprivation).
 ► Preference/need for carer presence in the 
intervention.
 ► Broad musical preferences (to inform planning of 
singing sessions).
Depending on recruitment patterns and due to the 
group format of intervention, eligible and consenting 
participants may have to wait several weeks before 
commencement of the intervention. They will be kept 
informed of timings by the TM using the participants’ 
preferred method of communication (telephone, email 
or post).
Clinical outcomes
All clinical outcome measures will be collected for all 
participants during face-to-face assessments in their 
own home at baseline by the TM or ARF and at 3 and 
6 months postrandomisation by a research practitioner 
blind to trial arm allocation. Measures include: (1) Well-
being (ICECAP-A)45; (2) Stroke and Aphasia Quality 
of Life Scale (SAQOL)46; (3) EuroQol Quality of Life 
Scale (EQ-5D-5L)47; (4) Social participation (modified 
Reintegration to Normal Living (mRNL) Index)48; (5) 
Communication (COAST)49; (6) Aphasia (Very Short 
Version of the Minnesota Aphasia Test)43 and care related 
quality of life (CarerQoL 7-D)50 for carers. Health and 
social service use will be measured through a Service 
Receipt Inventory.51 Adverse events will be reported for 
the week prior to the research visit. Table 1 indicates 
the outcome instruments and the time points for their 
administration.
Feasibility, acceptability and process outcomes
The feasibility of a definitive RCT will be determined 
by collecting and analysing the following pilot study 
data: (1) Numbers and details of those approached; 
(2) Recruitment and retention rates, including recruit-
ment patterns from each route and geographical area. 
Those who decline to participate or who drop out of the 
study will be asked to provide their reasons for this; (3) 
Acceptability of randomisation; (4) outcome measure-
ment burden; (5) interventions and other aspects of trial 
participation will be investigated by checking completion 
of questionnaires as well as through interviews with 15 
participants (purposively selected to ensure inclusion of 
different genders, ages, time since stroke (under/over 
1 year), severity of aphasia, past experience of singing, 
Table 1 Trial outcome measures and when used (1=baseline; 2=3-month follow-up; 3=6-month follow-up)
Measure
Time Assessment
(min) 1 2 3
ICEpop CAPability measure for Adults (ICECAP-A)45
  A 5-item measure of capability for the general adult (18+) population for use in economic evaluation. 
It focuses on well-being and comprises five attributes: Attachment, Stability, Achievement, 
Enjoyment, Autonomy.
10 ✓ ✓ ✓ 
Stroke and Aphasia Quality of Life Scale (SAQOL–39)46
  A 39-item health-related quality of life measure with four subdomains: physical, psychosocial, 
communication and energy.
20 ✓ ✓ ✓ 
EQ-5D-5L47
  A 6-item measure of health-related quality of life that can be used for cost utility analysis. 10 ✓ ✓ ✓ 
modified Reintegration to Normal Living (mRNL)48
  An 11-item measure that captures social participation (eg, recreation, movement in the community 
and interaction in family or other relationships).
10 ✓ ✓ ✓ 
Communication Outcome After STroke (COAST)49
  A 20-item measure of communication effectiveness for people with any type of communication 
problem following stroke
20–25 ✓ ✓ 
Very Short Version of the Minnesota Aphasia test43
  A diagnostic tool to identify aphasia type. Comprised four activities: Identifying names, oral reading 
words, naming pictures and written spelling. Audio-recorded to allow for diagnosis of aphasia 
severity.
15 ✓ ✓ 
Service Receipt Inventory51
  Record of types and amount of use of health and social care resources including clinical contacts, 
formal and informal social care. Completed by Assessor drawing on participant and family accounts.
20 ✓ ✓ 
Care related Quality of Life (CarerQoL-7D)48
  For completion by carers. A 7-item measures of the impact of providing informal care on carers. 
Utility tariffs to calculate a weighted sum score of the CarerQol-7D are also available.
5 ✓ ✓ 
Adverse incidents52 10 ✓ ✓ 
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trial arm and cohort location) and by interviews with the 
singing group facilitators and singing champions. These 
qualitative interviews will use a semistructured interview 
schedule designed to cover the above issues and will ask 
about other personal and contextual factors that may 
affect participation and outcomes (ie, barriers and facili-
tators) including what refinements might be needed for 
the definitive trial delivery. Interviews will be conducted 
by a member of the research team at a convenient time 
and location for the participant after the intervention 
period; (6) Any adverse events52 will be identified, via 
singing group facilitator reports and the research staff 
explicitly questioning participants during the follow-up 
assessments, using trial standard operating procedures 
(no adverse events were reported in our development 
study); (7) Intervention fidelity will be assessed by several 
methods: singing group attendance, session checklists, 
observations and video recordings of selected singing 
group sessions in the programme (undertaken by the TM 
or ARF).
Usual care
Participants in both intervention and control arms may 
receive health and social care as part of their usual care, 
and these will be recorded using the Service Receipt 
Inventory.
Foreseen difficulties
(1) ‘Singing for aphasia’ may be seen by some as implying 
that the intervention is aimed specifically at improving 
language function of people with aphasia. Our SUG and 
development study participants strongly advised that we 
emphasise the well-being and quality of life benefits of SPA 
over its potential for impacting language function (there 
is very little supporting empirical evidence for the latter 
impact). Nevertheless, we will be assessing the impact of 
the singing group on speech and language. Our patient-
facing materials reflect this. (2) Timing: as a group inter-
vention, some of those who give consent to take part may 
have to wait several weeks until the SPA programme is 
ready to commence. The study team will maintain brief 
but regular contact with those waiting. The feasibility and 
acceptability of this process, including the wait time and 
recruitment/retention issues more generally, are part of 
what is being tested in this pilot study. (3) Burden (partic-
ipant): particularly completion of the battery of measures 
and travel to intervention venue. These were deemed 
acceptable by most participants in our preliminary work. 
However, rather than asking participants to complete all 
questionnaires in one long session, we will offer to make 
multiple visits. To ensure we do not overburden partici-
pants, these visits will be restricted to no more than 1 hour 
(unless participants wish to continue beyond 1 hour) and 
will allow participants to take breaks as required. There 
may also be burden on carers: they may need to provide 
travel to and from the 10 weekly singing sessions at the 
community centre venues for participants in the interven-
tion arm. (4) Facilitator availability: we will have secured 
the input of a singing facilitator through a community 
organisation in Plymouth and another facilitator, via local 
contacts, for the cohorts in South Devon and Exeter.
Service user involvement
Stroke survivors, their partners and carers have been 
consulted at all stages of the work leading to this protocol. 
Our patient and public involvement (PPI) representa-
tives have materially influenced decisions on the study 
population, promotion and recruitment, the nature of 
the SPA intervention and how its effectiveness should be 
assessed. One experienced PPI representative will be part 
of the Trial Management Group (TMG), and another will 
join the Trial Steering Committee (TSC). A total of nine 
people have joined our SUG for this pilot study and will 
contribute by reviewing study materials and documen-
tation, commenting on and proof reading reports and 
contributing to dissemination activities. This group has 
worked with us for several years already and will continue 
to be supported in their work by Peninsula Collabora-
tion for Leadership in Applied Health Research and 
Care (PenCLAHRC) PPI team, for example, by attending 
workshops on critical appraisal skills.
Data analysis
Given the feasibility objectives of this pilot study, the focus 
of data analysis will be descriptive. For both recruitment 
settings (North, East and West (NEW) Devon and South 
Devon), participant progression through the study will be 
reported using a CONSORT flow diagram. We will report 
recruitment rates by site and levels of attrition at 3 and 
6 months. The diagram will also reflect the number of 
recruitment letters sent, numbers consenting, number 
randomised, number undertaking intervention and 
number of completed outcomes alongside means and SD 
regarding the number, length and frequency of sessions. 
All protocol deviations, along with reasons and number 
of missing items on questionnaires will be reported. 
Descriptive statistics (mean and SD or equivalent) will be 
reported for demographic data and all outcome measures 
at each assessment point for both the intervention and 
control groups. A longer follow-up assessment point (eg, 
12–24 months) needed for the definitive trial is beyond 
the scope of this pilot trial; however, we will use observed 
attrition at 3 and 6 months to model the potential level of 
attrition at longer follow-up.
For the trial process evaluation, we will use a thematic 
analysis for the qualitative interview data and use several 
of the quantitative measures (including demographic, 
medical, video and questionnaire data) to help identify 
and understand potential mediators and moderators of 
trial outcome. For the analysis of intervention fidelity 
and engagement we will use trainer interview data, 
session checklists completed by facilitators (that will be 
part of the Intervention Delivery Manual), participant 
attendance data, researcher observations and videos 
of singing sessions. These data collection and analysis 
methods will be assessed for their potential to inform 
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the process evaluation component of a definitive trial. 
In such a future trial, the health economics analysis will 
be a cost-utility analysis, using Quality Adjusted Life 
Years and a secondary analyses will investigate the bene-
fits of the intervention more broadly within the frame-
work of a cost consequences approach, so offering the 
potential to weight different outcomes in a multicri-
teria decision analysis framework.51 In this pilot study, 
we will assess costs associated with intervention delivery 
as well as assess the feasibility of collecting health and 
social service resource use through a Service Receipt 
Inventory.
Study timeline
The broad timetable for the research can be seen 
in table 2: 0–2 months: Staff training, study setup; 
2–8 months: Participant recruitment; 6–11 months: 
Intervention delivery; 8–13 months: Qualitative data 
collection and analysis; 8–17 months: Follow-up data 
collection (quantitative); 17–19 months: Data analysis; 
19–21 months: Write-up, revise intervention manual, 
final report, dissemination. Trial management, steering 
committee and SUG meetings will be held on 14 occa-
sions total across the 21 months of the study.
Patient and public involvement
PPI is central to the progression of the research 
study. The core research question was put forward by 
a stroke survivor who wanted to know what the bene-
fits of singing were for people with poststroke aphasia. 
Our SUG reviewed questionnaires and supported their 
transformation into aphasia friendly format. They also 
advised on study venue and structure of the singing 
group sessions. Our SUG will be kept informed on 
the progress of the study via regular newsletters and a 
final ‘dissemination’ meeting will be held with them to 
present results and seek advice on reporting findings 
to study participants. We will send a summary of results 
to all study participants in aphasia friendly format. We 
will have independent patient representatives on the 
TSC and TMG. The TMG member will contribute to the 
review and editing of all academic outputs and will be an 
important coauthor.
EthICs And dIssEMInAtIon
Ethics
The study will be conducted in accordance with the prin-
ciples of the International Conference for Harmonisation 
of Good Clinical Practice (ICH GCP) guidelines53 and the 
Research Governance Framework for Health and Social 
Care.54 Any amendments to the trial documents will be 
approved by the sponsor before submission to the REC 
and HRA. The University’s Clinical Trials insurance cover 
provides either legal liability cover or non-negligent/
no fault compensation cover.
We believe that the trial does not pose any specific 
risks to individual participants and nor does it raise any 
particular ethical issues. Based on results from our devel-
opment work, SPA is a low‐risk intervention. Individuals 
may report being distressed—either as a result of research 
activity or as a result of events in their private lives. Should 
such a situation arise, the researchers will implement the 
trial risk protocol and manage the participant in accor-
dance with this policy. Under high-risk situations (eg, 
where there is perceived immediate risk to a participants 
health), the study team may be required to break confi-
dentiality, to inform appropriate authorities who will 
need to provide essential care services. This information 
will be outlined in the Participant Information Sheet.
Participants will be informed of possible benefits and 
known risks of participation in the trial by means of 
a PIS and through discussion with the research team. 
All participants will sign a consent form approved by 
the ethics committee. They will be consented to partic-
ipating in the trial, being randomised and followed 
up, participating in and being audio-recorded during 
interview, being video-recorded in the singing sessions 
and being contacted in the future about this and other 
research. Individuals who are not able or not willing to be 
randomised will not be recruited. Individuals will be sent 
an additional PIS relating to the interview study. Written 
consent will be obtained again immediately prior to the 
interview study; verbal consent will be obtained imme-
diately prior to any video-recording of singing sessions: 
these consent processes will allow participants to fully 
consider their participation and to confirm or change 
their original consenting decision.
Table 2 Study timeline
Months: 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Setup; staff training
Recruitment
Intervention delivery (singing programme × 3)
Qualitative data collection and analysis
Follow-up data collection (quantitative); 3 months and 
6 months
Data analysis (quantitative)
Write-up and reporting
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Governance and safety considerations
Drafts of the trial protocol have been reviewed by the 
Southwest Research Design Service and the CRN. The trial 
is registered with the  ClinicalTrials. gov: NCT03076736. 
This is a University of Exeter-sponsored research study, 
working in collaboration with NHS trusts.
Adverse events
As a non-physical intervention, there appears to be a low 
risk of serious adverse advents (AEs) associated with this 
study. Singing group facilitators will record any reported 
or witnessed AEs during the intervention and participants 
will be asked about AEs as part of the process evaluation 
(to maintain blinding of the outcomes assessor). All partic-
ipants will also be asked to report on adverse events over 
the preceding week during their follow-up assessments. 
Any serious AE52 will be immediately reported to the 
trial sponsor and relevant ethics committee if the Chief 
Investigator deems it related to the intervention and to 
the independent TSC members who are also acting as our 
Data Monitoring and Ethics Committee.
Trial monitoring and management
Day-to-day running of the trial will be the responsibility 
of the TM. Standard Operating Procedures will be 
followed for: (1) assessment processes and reporting; 
(2) data management; (3) adverse incidents monitoring, 
reporting and action and (4) study staff health and safety.
The core study team (CI, TM and ARF) will meet 
weekly during the study. The TMG will include all of the 
core study team, all funding coapplicants and a person 
with aphasia. The TMG will review progress and provide 
advice on study planning. The TMG will meet on six 
occasions. TSC meetings will be held (if necessary by 
teleconference) on four occasions. The TSC will discuss 
recruitment, withdrawals, study progress, process evalu-
ation and AEs and will advise on protocol amendments 
where necessary. The TSC will include academics with 
expertise in trial methodology, health economics, qual-
itative methods and process evaluation, a clinician with 
expertise in stroke and rehabilitation, a person with 
aphasia and a representative of the trial sponsor. Due to 
the low risk of AEs, an independent data monitoring and 
safety committee will not be appointed. Instead, we will 
appoint suitably qualified academics and clinicians to the 
TSC who will have responsibility for independently moni-
toring the safety and quality of the trial. A closed meeting 
prior to the TSC meetings will take place with the inde-
pendent members of the TSC who will also be responsible 
for oversight of the safety of the trial and data integrity 
(thereby taking on the role of the data monitoring and 
ethics committee).
Data management
All study data will be kept for 10 years under secure condi-
tions on University of Exeter secure servers. Data will also 
be subject to standard secure storage and usage policies. 
Data will be collected and retained in accordance with the 
UK Data Protection Act 1998 and the new General Data 
Protection Regulation 2018 and managed in accordance 
with the trial-specific standard operating procedure for 
data management. With their consent, participant details 
will be passed between NHS services and the research 
team by telephone, post or in person only (that is, not 
electronically). All enrolled participants will be allocated 
a unique study ID, and the information linking their 
ID to their personal details will be kept securely at the 
University of Exeter. All other participant-related paper 
records will be anonymised and stored separately from 
the personal information. The electronic database for the 
trial will be stored on the secure servers of the Univer-
sity of Exeter with password-controlled access provided 
for the research team by the Exeter Clinical Trials Unit. 
Double data entry with extensive in-built validity checks 
will be used to reduce the risk of transcription errors. 
The study database will include prompts for missing data 
and warnings to alert staff when values are entered that 
are outside of the expected range or if the type of value 
entered is incorrect (eg, a numeric value entered rather 
than text).
Audio and video recordings will be digitised, encrypted 
and stored on the University’s secure server. Audio 
recordings will be retained until after anonymised tran-
scripts have been finalised and analysed. At this stage, 
they will be securely and permanently deleted. All partic-
ipants (including carers and trainers) will provide verbal 
consent to video-recording on each occasion that it 
occurs. Everybody will be offered the option of having 
their image edited so they are not identifiable. Access 
to personal data will be restricted to the research team. 
Names and participant details will not be passed to any 
third parties and no named individuals will be included 
in the write-up of the results. All participants (people 
with aphasia, carers, singing group facilitators and music 
champions) will be asked for their consent for the study 
team to retain interview transcripts and video recordings 
for the purposes of future research by those involved 
directly in the study team or for educational purposes.
dissemination and impact activities
Trial progress will be reported to our SUG at meetings 
and through quarterly newsletters. At the end of the 
study, we will seek input from our SUG to help dissemi-
nate a lay summary of the findings to study participants.
We envisage a number of key papers arising from this 
pilot trial. A trial publication policy will be developed 
which outlines the strategic plan for dissemination. The 
results of the trial will be reported first to study collabora-
tors and to the funder (the Stroke Association). The main 
report will be drafted by the TMG and circulated to all 
collaborators and the TSC for comment.
Key outputs from the trial will contribute to our dissem-
ination and impact agenda: (1) Pilot data will inform the 
decision whether to proceed to a definitive RCT and, if so, 
we will have (2) the evidence to support a funding appli-
cation and (3) finalised Intervention Delivery manual to 
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enable multicentre replication of SPA; (4) presentations 
at national and international conferences, seminars and 
PPI events and (5) dissemination through internationally 
recognised peer reviewed journal publications (including 
open access web sources), newsletters and media releases.
Acknowledgements We would like to thank the Stroke Association for funding 
this pilot RCT. We are very grateful for PenCLAHRC for their support of the study 
and to the Peninsula Patient Involvement Group for helping guide the trial design. 
We would also like to thank Plymouth Music Zone (PMZ) for their support of the 
study. PMZ was involved in the early development work including intervention 
design and they will provide resource (staff and facilities) to support the delivery of 
the intervention. We would also like to thank our SUG for their contributions to the 
design and development of the research study. 
Contributors MT led the project team and the protocol development. RC, MT and 
MC wrote the first version of protocol and RC wrote all amendments for ethics 
submission. MT provided expertise on group processes in treatment settings. CC 
provided aphasia and speech and language expertise. RST provided statistical and 
trial methodological expertise. FCW provided statistical expertise and drafted the 
statistics data analysis plan. MC and SGD provided qualitative expertise and drafted 
the Health Economics analysis plan. SGD and MC provided process evaluation 
expertise. AS and PL provided health economic expertise. JA provided patient and 
public involvement expertise. RC and MC provided trial management expertise. All 
authors commented on the protocol and the manuscript.
Funding The trial is funded by the Stroke Association (QQ12 / TSA 2016/14). 
Excess treatment costs have been covered by South Devon and Torbay Clinical 
Commissioning Group, North East and West Devon Clinical Commissioning group, 
and the University of Exeter Medical School. This research was supported by the 
National Institute for Health Research (NIHR) Collaboration for Leadership in Applied 
Health Research and Care South West Peninsula at the Royal Devon and Exeter NHS 
Foundation Trust. We also acknowledge the support of the NIHR Clinical Research 
Network.
disclaimer The views expressed are those of the author(s) and not necessarily 
those of the NHS, the NIHR or the Department of Health.
Competing interests All authors report the Stroke Association funding for the 
work under consideration but no other conflicts of interest.
Patient consent Not required.
Ethics approval Ethical approval for the study has been granted by theHealth 
Research Authority (HRA) and NHS National Research Ethics Service andResearch, 
via the Southwest – Frenchay Research Ethics Committee (17/SW/0060). 
Provenance and peer review Not commissioned; peer reviewed for ethical and 
funding approval prior to submission.
data sharing statement Not relevant at this stage.
open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non-commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
rEFErEnCEs
 1. The Stroke Association. State of the Nation Stroke Statistics 2016, 
2017. https://www. stroke. org. uk/ sites/ default/ files/ stroke_ statistics_ 
2015. pdf. (accessed 16 Feb 2017).
 2. Devon Wide Stroke Group. Health Equity Profile for Stroke, 2009.
 3. Cruice M, Worrall L, Hickson L. Quantifying aphasic people's 
social lives in the context of non‐aphasic peers. Aphasiology 
2006;20:1210–25.
 4. Dalemans RJ, De Witte LP, Beurskens AJ, et al. An investigation 
into the social participation of stroke survivors with aphasia. Disabil 
Rehabil 2010;32:1678–85.
 5. Hilari K, Northcott S, Roy P, et al. Psychological distress 
after stroke and aphasia: the first six months. Clin Rehabil 
2010;24:181–90.
 6. Brady MC, Kelly H, Godwin J, et al. Speech and language therapy 
for aphasia following stroke. Cochrane Database Syst Rev 
2012;16:Cd000425.
 7. Franzén-Dahlin A, Karlsson MR, Mejhert M, et al. Quality of life in 
chronic disease: a comparison between patients with heart failure 
and patients with aphasia after stroke. J Clin Nurs 2010;19(13-
14):1855–60.
 8. Dworzynski K, Ritchie G, Playford ED. Stroke rehabilitation: long-
term rehabilitation after stroke. Clin Med 2015;15:461–4.
 9. Howe TJ, Worrall LE, Hickson LMH. Interviews with people with 
aphasia: Environmental factors that influence their community 
participation. Aphasiology 2008;22:1092–120.
 10. Le Dorze G, Salois-Bellerose Émilie, Alepins M, et al. A description 
of the personal and environmental determinants of participation 
several years post-stroke according to the views of people who have 
aphasia. Aphasiology 2014;28:421–39.
 11. Fisher WA, Fisher JD, Harman J. The information-motivation-
behavioral skills model: a general social psychological approach to 
understanding and promoting health behavior. Social Psychological 
Foundations of Health and Illness: Blackwell Publishing Ltd 
2009:82–106.
 12. Tamplin J, Baker FA, Jones B, et al. 'Stroke a Chord': the effect of 
singing in a community choir on mood and social engagement for 
people living with aphasia following a stroke. NeuroRehabilitation 
2013;32:929–41.
 13. Clift SH, Staricoff G, Whitmore R. Singing and Health: A systematic 
mapping and review of non-clinical research: Sidney De Haan 
Research Centre for Arts and Health, 2008.
 14. Skingley A, Clift SM, Coulton SP, et al. The effectiveness and cost-
effectiveness of a participative community singing programme 
as a health promotion initiative for older people: protocol for a 
randomised controlled trial. BMC Public Health 2011;11:142.
 15. Clift SH G. The significance of choral singing for sustaining 
psychological wellbeing: findings from a survey of choristers in 
England, Australia and Germany. Music Performance Research 
2010;3:79–96.
 16. Haslam SA, Jetten J, Postmes T, et al. Social identity, health and 
well-being: an emerging agenda for applied psychology. Appl 
Psychol 2009;58:1–23.
 17. Tarrant M, Hagger MS, Farrow CV. Promoting positive orientation 
towards health through social identity. The social cure: Psychology 
Press 2011:39–54.
 18. Haslam C, Jetten J, Cruwys T, et al. The new psychology of health: 
Unlocking the social cure. Routledge, 2018.
 19. Cameron JE, Voth J, Jaglal SB, et al. "In this together": Social 
identification predicts health outcomes (via self-efficacy) in a chronic 
disease self-management program. Soc Sci Med 2018;208:172–9.
 20. Tarrant M, Khan SS, Farrow CV, et al. Patient experiences of a 
bariatric group programme for managing obesity: a qualitative 
interview study. Br J Health Psychol 2017;22:77–93.
 21. Oyserman D, Fryberg SA, Yoder N. Identity-based motivation and 
health. J Pers Soc Psychol 2007;93:1011–27.
 22. Haslam C, Holme A, Haslam SA, et al. Maintaining group 
memberships: social identity continuity predicts well-being after 
stroke. Neuropsychol Rehabil 2008;18(5-6):671–91.
 23. Haslam C, Haslam SA, Jetten J, et al. The social treatment: the 
benefits of group interventions in residential care settings. Psychol 
Aging 2010;25:157–67.
 24. Knight C, Haslam SA, Haslam C. In home or at home? How collective 
decision making in a new care facility enhances social interaction 
and wellbeing amongst older adults. Ageing Soc 2010;30:1393–418.
 25. Shadden BA JP. Renegotiation of identity: The social context 
of aphasia support groups. Topics in Language Disorders 
2004;24:174–86.
 26. Haslam C, Cruwys T, Haslam SA, et al. Groups 4 Health: Evidence 
that a social-identity intervention that builds and strengthens 
social group membership improves mental health. J Affect Disord 
2016;194:188–95.
 27. Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating 
complex interventions: the new Medical Research Council guidance. 
BMJ 2008;337:a1655.
 28. Stuckey HL, Nobel J. The connection between art, healing, and 
public health: a review of current literature. Am J Public Health 
2010;100:254–63.
 29. Hurkmans J, de Bruijn M, Boonstra AM, et al. Music in the treatment 
of neurological language and speech disorders: A systematic review. 
Aphasiology 2012;26:1–19.
 30. Stahl B, Kotz SA, Henseler I, et al. Rhythm in disguise: why 
singing may not hold the key to recovery from aphasia. Brain 
2011;134:3083–93.
 31. Tomaino CM. Recovery of fluent speech through a musician's use of 
prelearned song repertoire: a case study. Music Med 2010;2:85–8.
 32. Tarrant M, Warmoth K, Code C, et al. Creating psychological 
connections between intervention recipients: development and focus 
copyright.
 o
n
 February 28, 2020 at University of G
lasgow. Protected by
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-025167 on 10 September 2018. Downloaded from 
12 Tarrant M, et al. BMJ Open 2018;8:e025167. doi:10.1136/bmjopen-2018-025167
Open access 
group evaluation of a group singing session for people with aphasia. 
BMJ Open 2016;6:e009652.
 33. Schlaug G, Norton A, Marchina S, et al. From singing to speaking: 
facilitating recovery from nonfluent aphasia. Future Neurol 
2010;5:657–65.
 34. Pearce E, Launay J, Dunbar RI. The ice-breaker effect: singing 
mediates fast social bonding. R Soc Open Sci 2015;2:150221.
 35. Ali M, Bath PM, Lyden PD, et al. Representation of people with 
aphasia in randomized controlled trials of acute stroke interventions. 
Int J Stroke 2014;9:174–82.
 36. Brady MC, Fredrick A, Williams B. People with aphasia: capacity to 
consent, research participation and intervention inequalities. Int J 
Stroke 2013;8:193–6.
 37. Gov.UK. Mental Capacity Act 2005. London: HMSO, 2005.
 38. Browne RH. On the use of a pilot sample for sample size 
determination. Stat Med 1995;14:1933–40.
 39. Dean SG, Poltawski L, Forster A, et al. Community-based 
rehabilitation training after stroke: results of a pilot randomised 
controlled trial (ReTrain) investigating acceptability and feasibility. 
BMJ Open 2018;8:e018409.
 40. Siemonsma PC, Walker MF. Practical guidelines for independent 
assessment in randomized controlled trials (RCTs) of rehabilitation. 
Clin Rehabil 1997;11:273–9.
 41. Clemensen J, Larsen SB, Kyng M, et al. Participatory design 
in health sciences: Using cooperative experimental methods in 
developing health services and computer technology. Qual Health 
Res 2007;17:122–30.
 42. Wherton J, Sugarhood P, Procter R, et al. Co-production in practice: 
how people with assisted living needs can help design and evolve 
technologies and services. Implement Sci 2015;10:75.
 43. Powell GE, Bailey S, Clark E. A very short version of the minnesota 
aphasia test. Br J Soc Clin Psychol 1980;19:189–94.
 44. Bruno A, Akinwuntan AE, Lin C, et al. Simplified modified rankin 
scale questionnaire: reproducibility over the telephone and validation 
with quality of life. Stroke 2011;42:2276–9.
 45. Al-Janabi H, Flynn TN, Coast J. Development of a self-report 
measure of capability wellbeing for adults: the ICECAP-A. Qual Life 
Res 2012;21:167–76.
 46. Hilari K, Byng S, Lamping DL, et al. Stroke and Aphasia Quality of 
Life Scale-39 (SAQOL-39): evaluation of acceptability, reliability, and 
validity. Stroke 2003;34:1944–50.
 47. Herdman M, Gudex C, Lloyd A, et al. Development and preliminary 
testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life 
Res 2011;20:1727–36.
 48. Miller A, Clemson L, Lannin N. Measurement properties of a modified 
Reintegration to Normal Living Index in a community-dwelling adult 
rehabilitation population. Disabil Rehabil 2011;33(21-22):1968–78.
 49. Long A, Hesketh A, Paszek G, et al. Development of a reliable 
self-report outcome measure for pragmatic trials of communication 
therapy following stroke: the communication outcome after stroke 
(COAST) scale. Clin Rehabil 2008;22:1083–94.
 50. Brouwer WB, van Exel NJ, van Gorp B, et al. The CarerQol 
instrument: a new instrument to measure care-related quality of life 
of informal caregivers for use in economic evaluations. Qual Life Res 
2006;15:1005–21.
 51. Craig LE, Wu O, Bernhardt J, et al. Approaches to economic 
evaluations of stroke rehabilitation. Int J Stroke 2014;9:88–100.
 52. Carnes D, Mullinger B, Underwood M. Defining adverse events in 
manual therapies: a modified Delphi consensus study. Man Ther 
2010;15.
 53. Agency EM. Guideline for good clinical practice E6(R2. London: 
European Medicines Agency, 2016.
 54. Department of Health. Research Governance Framework for Health 
and Social Care. 2 edn. London, 2005.
copyright.
 o
n
 February 28, 2020 at University of G
lasgow. Protected by
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-025167 on 10 September 2018. Downloaded from 
